about
Occupational and environmental exposures as risk factors for systemic lupus erythematosus.Acupuncture in the treatment of rheumatic diseasesThe immune pathogenesis of scleroderma: context is everythingEffectiveness of transcutaneous electrical nerve stimulation for treatment of hyperalgesia and painEconomic Theory and Self-Reported Measures of Presenteeism in Musculoskeletal DiseaseGout Classification Criteria: Update and ImplicationsNon-invasive Loading Model of Murine OsteoarthritisUrate Handling in the Human BodyA Review of Patient Preferences for Osteoporosis Drug TreatmentGenetically Engineered Mouse Models Reveal the Importance of Proteases as Osteoarthritis Drug TargetsThe rationale for BAFF inhibition in systemic lupus erythematosusPatient reported outcomes in rheumatoid arthritis clinical trialsPreclinical rheumatoid arthritis (autoantibodies): an updated reviewClinical Tools to Assess and Monitor SpondyloarthritisThe role of the gut microbiota in the pathogenesis of antiphospholipid syndromeTissue-engineering strategies to repair chondral and osteochondral tissue in osteoarthritis: use of mesenchymal stem cellsImaging strategies for assessing cartilage composition in osteoarthritisBiomarkers for childhood-onset systemic lupus erythematosusAntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION): 5-Year UpdateEffect and treatment of chronic pain in inflammatory arthritisCholesterol crystals and inflammationThe Obesity Epidemic and Consequences for Rheumatoid Arthritis CareCellular Therapies in Systemic Sclerosis: Recent ProgressPharmacogenetics of treatment response in psoriatic arthritisRecent advances in the genetics of systemic sclerosis: toward biological and clinical significanceEvidence-based management of thrombosis in the antiphospholipid antibody syndromeUpdate on the management of the pregnant patient with antiphospholipid antibodyClinical trials in giant cell arteritisAppropriate management of antiphospholipid-related pregnancy in women without lupus who have low titer autoantibodiesThe epidemiology of the antiphospholipid syndrome: who is at risk?Kawasaki disease: an updateNew therapies and preventive strategies to treat and minimize damage in lupusTreatment and monitoring of patients with antiphospholipid antibodies and thrombotic history (Hughes syndrome)Update on the treatment of Kawasaki disease in childhoodManagement of the antiphospholipid syndromeAspirin, NSAIDs, and COX-2 inhibitors in cardiovascular disease: possible interactions and implications for treatment of rheumatoid arthritisUpdate on colchicine and its mechanism of actionKawasaki disease: 40 years after the original reportGenetics and mechanisms of crystal deposition in calcium pyrophosphate deposition diseaseNew developments in clinically relevant mechanisms and treatment of hyperuricemia
P1433
Q23913180-378460CA-62D8-4290-8495-27E240D17F92Q24608964-25106E67-3B00-4263-9E03-8D7CC84F0E1FQ24633658-C98E597D-2585-43D2-893A-883B01C28937Q24651867-7FF0B5EE-6D5B-4F0A-83C0-0E46DC483EFBQ26741224-AB98BA12-E03A-49E9-8CD0-DE39D1C87964Q26747158-29183CCD-1207-4AD8-95AB-AD54813F6230Q26749587-4A89C0D8-E9D6-44C4-8745-1ED6C04375F6Q26750896-D082E778-AB23-4082-AA94-BD29ECB706E2Q26796811-8F5E9404-314D-4B9C-A219-F1BA97874B5AQ26822238-1493257A-0D55-49EF-81B5-AA34CE3E4E06Q26827373-A6CB74C1-39B9-4186-B8E4-2518962A2F22Q26852960-978AE14A-E515-4504-BAD3-E148BF44E0BAQ26863441-342914E0-96E9-4466-BBA9-B7811C7BD8E0Q26866120-3F323436-8BCE-4EB8-8C8B-637611D750F3Q26866133-E68E071C-6C64-4C54-8BEF-AA8F5445AADFQ26995215-63913E40-5646-4747-8BCB-0FA1CA4C58CFQ27005276-664D5C65-E0F7-4DCF-BD4F-52DBC5E87EE2Q27007470-15781FD4-9ADB-4571-925E-451E344FF612Q27007774-ED9198CD-5D40-4306-ACED-84F8D1863B7CQ27014877-F47D3CCB-5C6F-42C5-9618-B94D561698E2Q27024737-C88756EA-761B-498B-98FD-D5EEB545DC4BQ28074864-54341AF3-4FAF-42CC-9A8C-C436CF6F74C8Q28080323-06C41590-8A8E-4EA1-8D97-B0B09ACF8A4CQ28081252-D09FC33E-F702-4A70-A633-2EBB733148A5Q28088499-4EDC93C6-D5EC-47F3-B783-AB015C501893Q28165262-69BF1C91-7560-4174-ADC4-E43D3929D50FQ28183591-0766BFFE-E354-4EA0-86B2-7D3BDCCFB4FCQ28185374-F920CC4F-9513-44B7-ABD6-299649CBBE9BQ28186800-B7C55563-CD22-41C6-9AAA-44C1228C53F5Q28186810-D361363C-ECC1-47E3-BAE5-D64A095192D9Q28192172-027E92BD-73E4-49B7-9935-8222AD75E2AEQ28193487-A9843252-F4A7-4F6E-B8B1-473FF41305D9Q28193706-3C14402F-4188-4DA5-89F0-E192B6B7DC3AQ28194172-84BA73CE-600B-4772-8A38-0FB78BB268BDQ28196178-CB4CC86D-972D-4936-9458-2ECDF2A24F08Q28212591-FE22D16C-CB0A-40C6-B25B-69EC929393CEQ28217460-D7C1FB72-C444-448C-AA9E-5A9B8C8B0FCBQ28219279-E041A067-E9F3-467D-BAB9-3CBDC6A5E014Q28256142-61D4228E-A1CA-4CA9-AEF9-F025711CFDE6Q28256994-3857776F-BECE-4A94-91D5-C1DAB51930E7
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van Springer Science+Business Media
@nl
wissenschaftliche Fachzeitschrift
@de
مجلة
@ar
name
Current Rheumatology Reports
@ast
Current Rheumatology Reports
@en
Current Rheumatology Reports
@es
Current Rheumatology Reports
@it
Current Rheumatology Reports
@nl
type
label
Current Rheumatology Reports
@ast
Current Rheumatology Reports
@en
Current Rheumatology Reports
@es
Current Rheumatology Reports
@it
Current Rheumatology Reports
@nl
prefLabel
Current Rheumatology Reports
@ast
Current Rheumatology Reports
@en
Current Rheumatology Reports
@es
Current Rheumatology Reports
@it
Current Rheumatology Reports
@nl
P3181
P1055
P1156
P1250
P1476
Current Rheumatology Reports
@en